
|Articles|August 1, 2017
- Pharmaceutical Executive-08-01-2017
- Volume 37
- Issue 8
Pharmaceutical Executive, August 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive August 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Health Policy Problem Solver: Fumie Griegoalmost 9 years ago
Dealmaking in 2017: Striking a Balancealmost 9 years ago
Beyond the Science: Commercial Implications From ASCO 2017almost 9 years ago
News Spotlight: Pharmaalmost 9 years ago
Pharma’s Marijuana Makeoveralmost 9 years ago
The 'Hear' and Now for Pharma and Social Mediaalmost 9 years ago
Pressure Mounts on FDA, Pharma to Tackle Opioid Abusealmost 9 years ago
Syncing Social Media With Value-Care Modelalmost 9 years ago
AI-based Social Listening as Aid to Pharmacovigilancealmost 9 years ago
Country Report: IndonesiaAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results
2
Where Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?
3
How Behavioral and Engagement Insights Improve Persistence in Patient Support Programs
4
Novavax's Strategy Across Commercial, R&D, and Partnerships
5




